APA (7th ed.) Citation

MJ, S., E, M., NR, M., R, G., FM, R., KP, S., . . . SJ, C. (2019). Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors. Nature communications, 10(1), 5167. https://doi.org/10.1038/s41467-019-12409-w

Chicago Style (17th ed.) Citation

MJ, Sale, et al. "Targeting Melanoma's MCL1 Bias Unleashes the Apoptotic Potential of BRAF and ERK1/2 Pathway Inhibitors." Nature Communications 10, no. 1 (2019): 5167. https://doi.org/10.1038/s41467-019-12409-w.

MLA (9th ed.) Citation

MJ, Sale, et al. "Targeting Melanoma's MCL1 Bias Unleashes the Apoptotic Potential of BRAF and ERK1/2 Pathway Inhibitors." Nature Communications, vol. 10, no. 1, 2019, p. 5167, https://doi.org/10.1038/s41467-019-12409-w.